Clinical trial
Axonal Excitability Measured by QTRAC Technique in Patients With Anti-MAG Neuropathy
NCT02468596 is registered in ClinicalTrials.gov with Fondation Ophtalmologique Adolphe de Rothschild as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Axonal Excitability Measured by QTRAC Technique in Patients With Anti-MAG Neuropathy
- Lead sponsor
- Fondation Ophtalmologique Adolphe de Rothschild
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- November 30, 2014
- Completion date
- February 28, 2022
- Enrollment
- 6 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
peripheral neuropathy associated with anti-myelin associated glycoprotein antibodies (anti-mag neuropathy)